tert-Butyl (2,2-difluoro-3-hydroxypropyl)carbamate

Catalog No. :
ACODFP706
CAS No. :
1314398-21-4
Molecular Formula :
C8H15F2NO3
Molecular Weight :
211.21

IUPAC Name:tert-butyl (2,2-difluoro-3-hydroxypropyl)carbamate

tert-Butyl (2,2-difluoro-3-hydroxypropyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$86.00Login to see priceIn stockInquiry
250mg97%$129.00Login to see priceIn stockInquiry
1g97%$367.00Login to see priceIn stockInquiry
5g97%$1072.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (2,2-difluoro-3-hydroxypropyl)carbamate
IUPAC Nametert-butyl (2,2-difluoro-3-hydroxypropyl)carbamate
MDL No.MFCD20483313
Molecular FormulaC8H15F2NO3
Molecular Weight211.21
SMILESO=C(OC(C)(C)C)NCC(F)(F)CO
InChI KeyGRLXPWNOGXJUKG-UHFFFAOYSA-N
Synonymtert-butyl 2,2-difluoro-3-hydroxypropylcarbamate;Carbamic acid, N-(2,2-difluoro-3-hydroxypropyl)-, 1,1-dimethylethyl ester;3-(Boc-amino)-2,2-difluoro-1-propanol;1,1-Dimethylethyl N-(2,2-difluoro-3-hydroxypropyl)carbamate
CAS No.1314398-21-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACODFP706 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFLAP386 route compound structure diagram
    ACFLAP386155310-11-5 In Stock
  4. Then
  5. ACODFP706 route product structure diagram
    ACODFP7061314398-21-4 In Stock
Inquiry

2. ACODFP706 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACODFP706 route product structure diagram
    ACODFP7061314398-21-4 In Stock
Inquiry

Comments (0)